Cellular

Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing

Retrieved on: 
Mercoledì, Maggio 29, 2024
Technology, Research, Genetics, Health Technology, Biotechnology, Health, Robotics, Other Science, Science, Constellation, Partnership, Stevenage, MIC, Cell, Patient, Automation, Risk, TTP, FDA, CGT, Gene, Cellular, ATMP, GMP, Pharmaceutical industry

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.

Key Points: 
  • Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, today announced a collaboration to demonstrate universal automation of CGT manufacturing.
  • The partnership will undertake the physical and digital integration of existing bioprocessing equipment at the CGT Catapult’s Stevenage Manufacturing Innovation Centre (MIC) using Cellular Origins’ robotic platform, Constellation™.
  • 2023 was a landmark year for the CGT industry, further demonstrating the growing need to scale CGT manufacturing.
  • CGT Catapult’s experience in establishing GMP facilities and optimising cell therapy manufacture is directly aligned with Cellular Origins’ mission to prove the impact automated manufacturing can have in transforming cell therapy production.

Comedy vs Cancer Sells Out Jazz at Lincoln Center

Retrieved on: 
Giovedì, Maggio 9, 2024
Volunteering, FDA, Bone marrow, Jazz, Cellular, Lincoln, Immunotherapy, Research, AML, Life, Blood, Comedy, MSK, Pediatrics, Acute myeloid leukemia, Clinical trial, Growth

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Comedy vs Cancer, Memorial Sloan Kettering Cancer Center’s (MSK) official comedy benefit show for blood cancer research, raised over $1.3 million on Tuesday, May 7. Over 1,000 supporters attended the one-night-only event at Jazz at Lincoln Center’s Frederick P. Rose Hall in New York City.

Key Points: 
  • NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Comedy vs Cancer , Memorial Sloan Kettering Cancer Center’s (MSK) official comedy benefit show for blood cancer research, raised over $1.3 million on Tuesday, May 7.
  • Over 1,000 supporters attended the one-night-only event at Jazz at Lincoln Center’s Frederick P. Rose Hall in New York City.
  • “Without funding from Comedy vs Cancer, we wouldn’t be where we are today — advancing immunotherapy for blood cancers,” said Dr. Curran, the Pediatric Director of the Cellular Therapeutic Center at MSK.
  • Comedy vs Cancer was founded by Niccole and Jeremy Kroll, Jennifer Rogers and Robert Carlock, and Nick Kroll and Lily Kwong.

Avive Solutions Raises $56.5M in Growth Funding To Build Connected AED Network and Transform Cardiac Arrest Emergency Response in Communities Nationwide

Retrieved on: 
Giovedì, Aprile 18, 2024
FDA, SCA, School, Partnership, Cardiac arrest, Growth, RapidSOS, Connect, CPR, IDEA, AED, Map, Service, Wi-Fi, SMS, SAN, GPS, Equity, Ecosystem, International, EMS, Federation, Survival, Shock, Medical device, Medicine, Gold, Organization, City, Internet, Cellular, Federal, University, Bluetooth, Patient, Police

, the developer of the world's most advanced connected automated external defibrillator (AED) - the Avive Connect AEDⓇ - today announced the closing of a $56.5 million growth equity financing.

Key Points: 
  • , the developer of the world's most advanced connected automated external defibrillator (AED) - the Avive Connect AEDⓇ - today announced the closing of a $56.5 million growth equity financing.
  • The Company also announced that Rik Vandevenne, Managing Partner at RC Capital, has joined Avive's Board of Directors.
  • Sudden Cardiac Arrest (SCA) is a massive healthcare challenge in the US, with over 430,000 lives lost each year to this devastating condition.
  • Avive's mission is to improve cardiac arrest survival rates by making AEDs ubiquitous: portable, ready-to-use devices in communities, schools, businesses, and homes.

Tan Delta Systems launches global Mining sector offering

Retrieved on: 
Giovedì, Marzo 21, 2024
Online, SIMPLE, ROI, VAR, Mining, REDUCE, Original equipment manufacturer, Cable, ESG, IP67, DAMAGE, Anomaly, Life, Wi-Fi, Cellular, Mineral, OEM, Ethernet, Gateway, Hearing, SITE, Maintenance (technical)

SHEFFIELD, United Kingdom, March 21, 2024 /PRNewswire-PRWeb/ -- Tan Delta Systems, the leading global manufacturer of real-time oil quality monitoring sensors and systems, announces the launch of its Mining & Mineral Processing sector offering.

Key Points: 
  • Tan Delta Systems, the leading global manufacturer of real-time oil quality monitoring sensors and systems, announces the launch of its Mining & Mineral Processing sector offering.
  • SHEFFIELD, United Kingdom, March 21, 2024 /PRNewswire-PRWeb/ -- Tan Delta Systems, the leading global manufacturer of real-time oil quality monitoring sensors and systems, announces the launch of its Mining & Mineral Processing sector offering.
  • Tan Delta has had a presence in the Mining & Mineral sector for some years and is now pressing ahead with the launch of its Mining and Mineral Processing sector-specific offering – one of its top eight target global sectors.
  • Chris Greenwood, CEO at Tan Delta Systems PLC, said: "We have always known our SENSE technology can add substantial value to the Mining & Mineral Processing sectors.

Onconova Therapeutics’ Rigosertib Poster Selected for AACR 2024

Retrieved on: 
Venerdì, Marzo 8, 2024
Assay, Cancer, JNK, NLRP3, AACR, IIS, Biochemistry, Cellular, Therapy, Reactive oxygen species, Tumor microenvironment, Patient, ROS, Research, Pharmaceutical industry

“The ability to impact multiple targets is an important characteristic of Onconova’s two lead clinical programs, rigosertib and narazaciclib.

Key Points: 
  • “The ability to impact multiple targets is an important characteristic of Onconova’s two lead clinical programs, rigosertib and narazaciclib.
  • We are pleased to present new preclinical studies that explore the molecular targets for rigosertib, in clinical development through a series of investigator initiated studies (IIS),” commented Steven Fruchtman, M.D., President and Chief Executive Officer of Onconova.
  • “The studies provide additional prospective on the main cellular pathways impacted by rigosertib, including RAS-MAPK signaling and reactive oxygen species (ROS)-related proteins.
  • Conclusions: This work identified a series of cellular and inflammatory targets that may be affected by rigosertib.

Global Cellular IOT Devices Markets, 2019-2022 and 2023-2029: Remote Monitoring and Control Transforming Operations, Interoperability and Standardization are Key Factors for Success

Retrieved on: 
Sabato, Marzo 9, 2024
Porter's five forces analysis, USD, Internet of things, Growth, SWOT, Smart, Life, Commercial, Cellular, Environmental monitoring, City, Consumer, Agriculture, IOT, Statistics, Research report, Internet, Mobile phone

Global Cellular IOT Devices Market report provides a complete analysis of the Global Cellular IOT Devices industry for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.

Key Points: 
  • Global Cellular IOT Devices Market report provides a complete analysis of the Global Cellular IOT Devices industry for the historical period of 2019-2022, the estimates of 2023 and the forecast period of 2024-2029.
  • With the ongoing evolution of cellular technologies, especially the emergence of 5G, the Cellular IoT Devices Market is poised for further growth.
  • The capability for remote monitoring and control is a transformative aspect of Cellular IoT Devices.
  • The report analyses the Global Cellular IOT Devices market by Device Type (Wearable Devices, Smart Appliances, Smart Parking Devices, Smart Meters, and Others).

Contactless Connector Market worth $480 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Mercoledì, Febbraio 28, 2024
EVS, Region, Wireless, Growth, ADAS, TE, Urbanization, Telecommunications, LTE-M, Transport, Security, Metal, UWB, Hardware, Data-rate units, Bluetooth, MIMO, Radio, Radiation therapy, Zigbee, NFC, RF, Consumer, IEEE Standards Association, European Union energy label, LTE, Contactless, EnOcean, Cellular, City, Processor, Building automation, Row, Economic development, GNSS, LoRa, Analytics, Device, Terrorism, Data, Communication, Z-Wave, STMicroelectronics, TE Connectivity, Control, Connectivity, Internet, Component, Consumer electronics, Mobile phone

Contactless connector market for radio frequency technology to hold the highest CAGR during the forecast period.

Key Points: 
  • Contactless connector market for radio frequency technology to hold the highest CAGR during the forecast period.
  • Contactless connector market for up to 6 Gbps data rate to hold the highest CAGR during the forecast period.
  • The contactless connector market for 6 Gbps data rate is experiencing significant growth due to several key factors.
  • These players have a strong market presence for Contactless connectors across various North America, Europe, Asia Pacific, and RoW countries.

Contactless Connector Market worth $480 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Mercoledì, Febbraio 28, 2024
EVS, Region, Wireless, Growth, ADAS, TE, Urbanization, Telecommunications, LTE-M, Transport, Security, Metal, UWB, Hardware, Data-rate units, Bluetooth, MIMO, Radio, Radiation therapy, Zigbee, NFC, RF, Consumer, IEEE Standards Association, European Union energy label, LTE, Contactless, EnOcean, Cellular, City, Processor, Building automation, Row, Economic development, GNSS, LoRa, Analytics, Device, Terrorism, Data, Communication, Z-Wave, STMicroelectronics, TE Connectivity, Control, Connectivity, Internet, Component, Consumer electronics, Mobile phone

Contactless connector market for radio frequency technology to hold the highest CAGR during the forecast period.

Key Points: 
  • Contactless connector market for radio frequency technology to hold the highest CAGR during the forecast period.
  • Contactless connector market for up to 6 Gbps data rate to hold the highest CAGR during the forecast period.
  • The contactless connector market for 6 Gbps data rate is experiencing significant growth due to several key factors.
  • These players have a strong market presence for Contactless connectors across various North America, Europe, Asia Pacific, and RoW countries.

Areteia Therapeutics Announces Appointment of Daniel Becker, M.D., Ph.D. To Board of Directors

Retrieved on: 
Giovedì, Febbraio 15, 2024
Chemicals, Plastics, Clinical Trials, Manufacturing, Biotechnology, Alternative Medicine, Health, Pharmaceutical, Other Science, Science, Boston, Champaign–Urbana metropolitan area, Health care, University, Multimedia, Hospital, Access, Boston Consulting Group, Molecular biology, Cellular, Oral medicine, Therapy, Patient, Internal medicine, Massachusetts General Hospital, Phase, Harvard Medical School, Nephrology

Areteia Therapeutics, Inc. (“Areteia”) today announced the appointment of Daniel Becker to the Areteia Board of Directors, effective immediately.

Key Points: 
  • Areteia Therapeutics, Inc. (“Areteia”) today announced the appointment of Daniel Becker to the Areteia Board of Directors, effective immediately.
  • Dr. Becker will serve as a member of the audit committee of the board.
  • View the full release here: https://www.businesswire.com/news/home/20240215803782/en/
    “I am excited that Dan has been appointed to our board,” said Jorge Bartolome, President and Chief Executive Officer of Areteia.
  • and Ph.D. (Cellular and Molecular Biology) degrees from the University of Michigan and received his B.S.

Virtual Internet Announces Virtual 5G for Android with 5G Guaranteed Level of Service

Retrieved on: 
Martedì, Febbraio 13, 2024
SAN, Social media, THG Ingenuity Cloud Services, Steam, Satellite, Cellular, Internet access, ISP, Android, Virtual, LAN, Wi-Fi, Cable, Internet, Mobile phone

SINGAPORE and SAN JOSE, Calif., Feb. 13, 2024 /PRNewswire/ -- Virtual Internet announced the Virtual 5G for Android, 5G Guaranteed Level of Service. It is a new level of performance specifically designed for Users that connect by Satellite and Cellular Radio.

Key Points: 
  • SINGAPORE and SAN JOSE, Calif., Feb. 13, 2024 /PRNewswire/ -- Virtual Internet announced the Virtual 5G for Android, 5G Guaranteed Level of Service.
  • With Virtual 5G for Android, 5G Guaranteed Level of Service not only will users receive faster service with Virtual 5G than without, Virtual 5G will enable users to average 5G level speeds on any network and any connection.
  • Virtual 5G for Android, has been re-engineered to deliver 5G Guaranteed Level of Service, especially important for Cellular and Satellite Internet.
  • Virtual 5G provides Global 5G Guaranteed Level of Service annually for less than these service providers charge for an hour of service.